Cough syrups produced in India are substandard: World Health Organization warns

Latest News today
(Image source: Pixabay)


Both cough syrups, Ambranol and Doc One Max, are classified as inferior by the WHO.

The United Nations World Health Organization has blocked Uzbekistan from using substandard Indian-made cough syrup. 

According to India's NDTV, the World Health Organization (WHO) said in its alert on Wednesday that cough syrups produced by Indian company Marion Biotech are substandard and do not meet quality standards. 

A report on the WHO website says that two substandard cough syrups were identified in Uzbekistan and reported to the World Health Organization on December 22 last year. 

Both Embranol and Doc One Max cough syrup are manufactured by the company Marion Biotech, based in the state of Uttar Pradesh. 

The statement adds that the company has not yet given any guarantee for the quality of these two drugs to the World Health Organization. 

It should be noted that a few days ago it was reported that some children in Uzbekistan have died after using this cough syrup produced in India. 

According to the World Health Organization, samples of cough syrup sent to a laboratory were found to contain unacceptable levels of diethylene glycol. 

The WHO has warned that these inferior products are unsafe to use, especially in children, which can lead to serious health problems or even death. 

The Department of Food Safety and Drugs in Uttar Pradesh has revoked the license of Marion Biotic after its use of the syrup in Uzbekistan allegedly killed 18 children.



Post a Comment

0 Comments